WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 38.74
+0.94 (2.49%)
Jul 31, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 158.98 billion as of July 31, 2026. Its market cap has increased by 17.64% in one year.
Market Cap
158.98B
Enterprise Value
151.37B
Revenue
24.25B
Ranking
n/a
PE Ratio
29.99
Stock Price
38.74
ChartMarket Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 158.98B, an increase of 396.21%. That is a compound annual growth rate of 19.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 158.98B | 22.33% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 288.08B |
| Innovent Biologics | 156.16B |
| Sichuan Kelun-Biotech Biopharmaceutical | 118.94B |
| Sino Biopharmaceutical | 93.12B |
| Akeso | 88.11B |
| RemeGen | 65.64B |
| Biocytogen Pharmaceuticals (Beijing) | 49.57B |
| 3SBio | 43.56B |